An experimental cancer vaccine kept melanoma from coming back. It’s the first successful late-stage mRNA study validating decades of custom-treatment research https://t.co/nfhZF7xwq1 ...

🚨 TODAY: Anthropic says Claude successfully designed novel protein binders from scratch for 14 of 15 targets, with Adaptyv Bio and Twist Bioscience independently validating the results. https://t.co/5UXqOkLzLr ...

Many drugs work by binding to a specific target in the body and blocking or changing what it does. An important first step in the drug development process is designing a molecule that can bind tightly to its target. Traditionally, that's meant weeks or months of expert work per target, sifting through a large number of candidates to identify the few that work.We wanted to test if Claude could successfully design novel protein binders from scratch (also called de novo design). With a protein design prompt wr ...

Let's get to Julia Leigh, investment director at Shaw and Partners Asset Management. Joining me right here in Sydney. Julia welcome.Great to be here, Tom. Uh, I want to pick up on what Heidi was saying there about BHP and the least number of buy ratings. I mean, copper, a great story for them today, but is it as great as it could have been.I think first of all, we have to applaud the results today. It's on the back of very strong operational performance together with rising prices and that dividend. You kno ...